NanoViricides
NNVC
#10132
Rank
C$30.9 M
Marketcap
C$1.72
Share price
0.82%
Change (1 day)
-16.12%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of June 2025 : C$12.31 Million

According to NanoViricides's latest financial reports the company's total assets are C$12.31 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2025)

Total assets by year

Year Total assets Change
2024-06-30C$17.53 M-21.62%
2023-06-30C$22.36 M-26.05%
2022-06-30C$30.24 M-19.35%
2021-06-30C$37.5 M15.53%
2020-06-30C$32.46 M84.39%
2019-06-30C$17.6 M-27.81%
2018-06-30C$24.38 M-30.48%
2017-06-30C$35.07 M-26.1%
2016-06-30C$47.46 M-13.9%
2015-06-30C$55.13 M17.8%
2014-06-30C$46.8 M171.33%
2013-06-30C$17.24 M8.39%
2012-06-30C$15.91 M53.48%
2011-06-30C$10.36 M8.91%
2010-06-30C$9.52 M176.07%
2009-06-30C$3.44 M130.57%
2008-06-30C$1.49 M4.5%
2007-06-30C$1.43 M-52.78%
2006-06-30C$3.03 M
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
C$0.62 B 4,959.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$1.64 B 13,271.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$81.71 B 663,232.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$135.25 B 1,097,906.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$180.84 B 1,467,996.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$115.11 B 934,392.89%๐Ÿ‡ฌ๐Ÿ‡ง UK